Cadre Holdings Inc

CDRE remains in an early Stage 1 base after a sharp decline, trading range-bound between ~$27.5 and ~$31.0. The 9- and 21-EMAs have repaired and are acting as support, with price tightly tracking above them and showing no exhaustion. Occasional expansion on up-legs and follow-through days signal emerging demand, though a mature base is still forming. With medium-term bias tilted bullish and supportive EMA interaction, buying on shallow pullbacks into the 9/21 EMA cluster near the lower half of the base is timely.

• ↑Net sales rose 19% YoY to $155.4M; backlog hit $355M for 2026 conversion.
• ↑2026 adjusted EBITDA outlook of $136M–$141M tied to pricing power and productivity.
• ↓Earnings yield weakness raises valuation concerns at current prices.